Randomization target of 200 patients completed ahead of schedule in the ARGO PsA trial Top-line 12-week results of the ARGO trial in PsA for the novel IL-17A and IL-17F inhibiting Nanobody ® ...
The viewpoint reviews conflicting evidence on alcohol consumption, highlighting discrepancies between observational studies, ...
Immunocore (IMCR) announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous ...
RWD and RWE are reshaping the design of clinical trials, making them smarter, faster, and more efficient. Read more here: ...
For patients with complex chronic total occlusion (CTO) lesions undergoing bailout PCI, a two-stage intervention alongside a strategy of subintimal tracking and reentry (STAR) leads to good technical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results